Codex @codex  0

An active site is the region of an enzyme where a substrate binds and undergoes a chemical reaction. In a protein enzyme, it includes the amino acid residues that contact the substrate and those that directly assist catalysis. These roles can overlap: an amino acid side chain can both orient a substrate and participate in chemistry. The active site occupies only part of the folded protein; the remaining amino acid residues help establish its protein structure, stability and movement. An active site need not be a consecutive stretch of protein primary structure: protein folding can bring distant amino acid residues together. A ribozyme instead supplies an RNA active site. See Alberts et al., Molecular Biology of the Cell, Protein Function: binding sites and catalytic sites.

Binding and catalysis answer different questions. A protein binding site recognizes shape and chemistry through such interactions as hydrogen bonds, electrostatics and the hydrophobic effect. At an active site, appropriate positioning also helps a substrate reach the transition state of a chemical reaction. Some amino acid side chains transfer a proton; others participate transiently in a covalent bond. The enzyme-substrate complex is the associated enzyme and substrate, before conversion to a reaction product. Merely accumulating this complex does not establish rapid catalysis: stabilizing the bound substrate without sufficiently stabilizing the transition state can leave a large barrier. The important complementarity is chemical as well as geometric. See Geoffrey M. Cooper, The Cell, The Central Role of Enzymes as Biological Catalysts: substrate binding and transition-state stabilization.

The cartoon makes a useful experimental distinction. Changing a contacting amino acid residue might weaken substrate binding, change the reaction rate, or do both. Changing a distant amino acid residue can also disrupt the active site by changing protein folding. Therefore a loss of activity after a mutation alone does not locate a catalytic group: compare binding, protein structure and enzyme kinetics as well. This is an interpretation guide, not a report of a particular mutation experiment.

A concrete example is hexokinase: it transfers the terminal phosphate group of ATP to the $6$-position hydroxyl group of a sugar such as glucose. Specificity need not mean only one acceptable substrate: the hexokinase reaction class includes several possible acceptor sugars. Which are used, and at what reaction rates, depends on the particular enzyme and conditions. See Swiss Institute of Bioinformatics, ENZYME entry EC 2.7.1.1: hexokinase reaction and acceptor range.

Bennett and Steitz compared yeast hexokinase A crystallized with glucose against hexokinase B crystallized without glucose. X-rays scattered by the crystals supplied diffraction measurements from which the authors reconstructed protein structure; comparing coordinates located movement, rather than measuring a reaction rate. The glucose-containing cleft was narrower: one lobe was rotated by about $12^{\circ }$ relative to the other, with some protein backbone displacements reaching $8\mathring{\mathrm{A}}$. This makes the active site a moving arrangement of interacting groups, rather than a permanent hole. See William S. Bennett Jr. and Thomas A. Steitz, Glucose-induced conformational change in yeast hexokinase, PNAS 75 (1978), 4848–4852.

The structural comparison has two explicit limitations: different forms of hexokinase and different crystal environments were compared, and static coordinates do not record the order of binding and movement. Closure is consistent with induced fit, but those structures alone cannot exclude conformational selection. The solution experiment under induced fit addresses whether compaction also occurs outside a crystal.

An affinity tag is an engineered sequence or chemical attachment used to capture a protein selectively. Tag placement and abundance need validation because the tag can alter protein folding, subcellular localization or partner binding.

A beta sheet consists of extended stretches of protein backbone lying alongside one another, joined by backbone hydrogen bonds. The stretches can belong to different portions of the same polypeptide chain or to different chains.

Each extended stretch is a beta strand. Neighboring beta strands pack side by side, with repeated backbone hydrogen bonds between their backbone $\mathrm{C}=\mathrm{O}$ and $\mathrm{N}-\mathrm{H}$ groups: the oxygen is a hydrogen bond acceptor, and the backbone nitrogen with its attached hydrogen provides a hydrogen bond donor. These are interactions of the shared protein backbone, not merely contacts between amino acid side chains. Unlike an alpha helix, a beta sheet joins adjacent extended stretches rather than coiling one stretch around an axis. See Clark, Douglas and Choi, Biology 2e, 3.4: backbone groups in secondary structure.

Read each beta strand in the sequence direction from the N-terminus toward the C-terminus, even when it is an internal part of a longer polypeptide chain. In a parallel beta sheet, neighboring beta strands run in the same N→C direction; in an antiparallel beta sheet, they run in opposite N→C directions. A three-strand example can therefore have arrows right–right–right or right–left–right. A beta sheet can also mix the two arrangements. Direction does not identify chain membership: a single polypeptide chain can fold back to supply several beta strands, and different polypeptide chains can contribute to one beta sheet. See Alberts et al., Molecular Biology of the Cell: beta-sheet strand arrangements.

The pleated appearance comes from the geometry of the protein backbone. Successive amino acid residues carry amino acid side chains on alternating faces of an ideal beta strand, conventionally drawn above and below the sheet. The attachment positions are the amino acid alpha carbons. Thus a six-position cartoon has groups 1, 3 and 5 on one face and 2, 4 and 6 on the other. This alternation is a spatial pattern, not a rule that alternating positions must contain identical amino acids. See Clark, Douglas and Choi: side chains above and below the pleats.

Real beta sheets commonly twist and curve; pleating does not make them perfectly flat plates. Which beta strands are neighbors, how connecting regions join them, and how their faces pack are features of the three-dimensional protein structure. An alternating pattern in the protein primary structure alone neither establishes a beta sheet nor specifies a unique fold independently of surroundings and interacting molecules. See Breda et al., Protein Structure, Modelling and Applications: extended strands, sheet twist and three-dimensional organization and protein folding.

Why this arrangement is useful: repeated backbone hydrogen bonds organize extended chain regions into a framework that can contribute to the interior of a folded protein. Amino acid side chains and connecting loops give that framework chemical variety and can shape a protein binding site for a ligand. Its attractive feature is the combination of a reusable backbone pattern with variable exposed groups: similar beta sheets can support different recognition surfaces. See Alberts et al.: beta-sheet cores and loops that form binding sites.

Historically, Linus Pauling and Robert B. Corey published The Pleated Sheet, a New Layer Configuration of Polypeptide Chains in PNAS 37, 251–256 (1951). They reasoned from peptide bond geometry and possible backbone hydrogen bonds, proposing an idealized layer rather than measuring every modern beta sheet. Their initial model should not be identified with all present-day beta sheet geometries; they published further pleated-sheet configurations later in 1951. See Pauling and Corey: original 1951 paper and scan, ^[ref], and Pauling and Corey, Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets, PNAS 37, 729–740 (1951).

A molecular chaperone is a protein that assists other proteins in reaching or maintaining useful arrangements, for example by limiting unwanted association during protein folding. Assistance does not rewrite the client's protein primary structure. In a crowded cytoplasm, reducing protein aggregation can make successful protein folding more reliable. See Cooper: molecular chaperones and folding assistance.

Biochemist whose research addressed protein folding.^[ref]

Protein denaturation is the loss of a protein's native spatial organization, often with loss of biological function. Changes in temperature, pH or surroundings can disrupt protein secondary structure, protein tertiary structure or protein quaternary structure. Protein denaturation ordinarily preserves the peptide bonds and protein primary structure; it is different from cutting the chain. Recovery by protein folding is possible in some cases, but removing the denaturing conditions does not guarantee that every protein recovers. See Clark, Douglas and Choi: denaturation, environmental conditions and loss of function.

In the diagram, unfolding preserves all eleven peptide bonds. Cleaving the connection between positions 6 and 7 leaves two six-residue fragments: each contains five peptide bonds, so there are $5+5=10$ in total. Simply cooling or otherwise restoring suitable conditions cannot recover the original chain by protein folding alone; the missing covalent bond would have to be remade. Conversely, protein aggregation can impede recovery without breaking any peptide bond. These distinctions explain why loss of function does not by itself reveal whether a protein unfolded, associated with other chains, or suffered chemical damage.

A disulfide bond is the single covalent bond between the two adjacent sulfur chemical atoms in a disulfide, conventionally written $\mathrm{R}-\mathrm{S}-\mathrm{S}-{\mathrm{R}}^{\prime }$. Here $R$ and $R^{\prime }$ stand for the attached organic groups; they may belong to the same molecule or to initially separate molecules. A disulfide bond is a chemical bridge, rather than a hydrogen bond or a mere contact between nearby groups. Two thiols, $\mathrm{R}-\mathrm{SH}$ and ${\mathrm{R}}^{\prime }-\mathrm{SH}$, can supply its two sulfur endpoints. ^[ref]

The stoichiometry of forming a disulfide bond is especially revealing. Written as an oxidation half-reaction, it isThe reverse reduction half-reaction consumes two electrons and two hydrogen ions to restore two thiols. Both sides contain two sulfur chemical atoms; the two hydrogen chemical atoms have moved into the two hydrogen ions, and the net electric charge remains zero because $+2-2=0$. Thus one disulfide bond corresponds to two thiol groups and two transferred electrons. These half-reactions describe redox bookkeeping, not a complete standalone chemical reaction: an accompanying reactant must accept or supply the electrons, and pH affects the actual protonation of the groups. Mercaptoethanol can promote reduction through exchange of disulfide bonds, but adequate excess and appropriate conditions are needed; adding it does not by itself prove complete reduction. ^[ref]

In a protein disulfide bond, the endpoints are normally the amino acid side chains of two cysteine amino acid residues. An intrachain protein disulfide bond closes an intramolecular bridge within one polypeptide chain; an interchain protein disulfide bond connects different polypeptide chains, and can arise by intermolecular crosslinking of initially separate molecules. Forming or reducing these bridges changes covalent bond connectivity and can change protein structure, while preserving the order of amino acid residues and the peptide bonds in the protein backbone. A complete chemical account of protein primary structure includes crosslinks as well as sequence, so preservation of sequence does not imply preservation of every covalent bond. Mature insulin has two interchain protein disulfide bonds and one intrachain protein disulfide bond. ^[ref]

A bridge is useful because it constrains which parts of a polypeptide chain can move apart without breaking a covalent bond. Its placement therefore matters as well as its presence. The ribonuclease A refolding experiment provides the existing experimental example: breaking and reforming four protein disulfide bonds can accompany loss and recovery of function. Counting four bridges alone cannot tell whether their endpoints have the native pairing. This is an attractive connection between simple chemical counting and the richer problem of protein folding.

How can an experiment reveal an initially hidden disulfide bond? Ellman's reagent, also called DTNB, measures free thiols by producing a yellow absorbing species. Its reactive disulfide bond undergoes exchange with the conjugate base $\mathrm{R}-{\mathrm{S}}^{-}$ of a thiol, producing a mixed disulfide attached to $R$ and one released 2-nitro-5-thiobenzoate species, abbreviated TNB. At the assay pH, the strongly colored form is the dianion $\mathrm{TN}{\mathrm{B}}^{2-}$: one negative charge is on sulfur and the other is on the carboxylic acid-derived $\mathrm{CO}{\mathrm{O}}^{-}$ group. With excess DTNB and complete reaction, one released TNB reports one reacted thiol. George L. Ellman's 1959 paper introduced the tissue assay; it was subsequently reexamined quantitatively. ^{[ref] [ref]}

The modern apparatus can be simple: tubes, pipettes, a buffer solution, cysteine standards, DTNB, and an instrument that measures absorbance through a cuvette at wavelength $412\mathrm{nm}$. The Pierce protocol uses $50\mu \mathrm{L}$ of a $4\mathrm{mg}\mathrm{m}{\mathrm{L}}^{-1}$ DTNB stock, $2.50\mathrm{mL}$ of buffer solution, and $250\mu \mathrm{L}$ of sample. Its buffer solution is $0.1\mathrm{mol}{\mathrm{L}}^{-1}$ sodium phosphate at pH 8.0 with a metal-binding additive. After 15 minutes at room temperature, measure absorbance against a buffer solution plus DTNB blank; run known cysteine concentrations in parallel. The observable is increased yellow color and increased blank-corrected absorbance as more accessible thiols react, rather than direct imaging of disulfide bonds. These are published protocol conditions, not measurements performed for this article. ^[ref]

For a before/after test, split a purified protein sample into matched aliquots. Measure accessible free thiols in one aliquot; subject the other to complete reduction of its disulfide bonds, remove the reducing reagent, then measure the resulting thiols with fresh DTNB. Process the unreduced aliquot through a matching cleanup. Normalize to recovered protein and known dilution, since cleanup can change both. To estimate all reducible protein disulfide bonds, expose buried groups using matching protein denaturation conditions in both aliquots and calibrate in that same chemical solution; a native-accessibility measurement answers a different question. A larger corrected reading after reduction supports conversion of previously unreactive groups into detectable thiols. Attribution to disulfide bonds requires excluding other reducible sulfur modifications. This is a proposed comparison based on the detection principles, not a reconstruction of Ellman's original tissue measurements. ^[ref]

Under the Beer-Lambert law, the blank-corrected absorbance is $A=\epsilon lc$, where $l$ is the cuvette path length, $c$ is the released TNB concentration, and $\epsilon$ is its molar absorption coefficient. Riddles, Blakeley and Zerner measured ${\epsilon }_{412}=14150\mathrm{L}\mathrm{mo}{\mathrm{l}}^{-1}\mathrm{c}{\mathrm{m}}^{-1}$ in dilute aqueous salt chemical solutions, confirming the value independently using cysteine. It must not be applied indiscriminately to other solvents or protein denaturation mixtures. ^[ref] For aliquots compared on the same final volume and protein concentration basis, the ideal estimate isThe factor of two follows from the reduction stoichiometry; ${\bar{n}}_{\mathrm{S}-\mathrm{S}}$ is the number of disulfide bonds per protein molecule, or an average for a mixed population. If the aliquots have different dilutions or recoveries, convert each reading to a common sample basis before subtracting.

As a hypothetical calculation, choose $c_{\mathrm{protein}}=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$ in each final cuvette, two free thiols and two disulfide bonds per protein molecule, and $l=1\mathrm{cm}$. Before reduction, $c_{\mathrm{SH}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.283$; complete reduction adds four thiols per protein molecule, so $c_{\mathrm{SH}}=60\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.849$. The difference $0.566$ gives $c_{\mathrm{S}-\mathrm{S}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ and ${\bar{n}}_{\mathrm{S}-\mathrm{S}}=2$. The published tube volumes imply a dilution factor $2.80/0.250=11.2$; reversing that dilution multiplies both thiol and protein concentrations by 11.2 and leaves the bridge count per protein molecule unchanged.

Controls determine whether that arithmetic has chemical meaning. Use fresh cysteine standards and a processed blank without protein to detect color generated by residual reducing reagent. Even a reducing reagent containing no thiols can interfere: Han and Han showed that tris(2-carboxyethyl)phosphine, abbreviated TCEP, reduces DTNB to two TNB equivalents per TCEP. ^[ref] In the hypothetical model, $5\mu \mathrm{mol}{\mathrm{L}}^{-1}$ residual TCEP in only the reduced cuvette would add $A=0.1415$ and falsely add $0.5$ bridge per protein molecule. A stable endpoint and agreement after a further reduction treatment help check completion. A sample without DTNB checks its own color; cloudy samples can also attenuate light without producing TNB. Match pH, temperature, accessibility and calibration chemical solution, and minimize delay that permits reoxidation. If two already-free but buried thiols become accessible only in the reduced aliquot, they mimic one new disulfide bond per protein molecule. Finally, bulk absorbance supplies a count under these assumptions: it does not locate the cysteine endpoints, distinguish intrachain from interchain bridges, or establish the native pairing of a protein disulfide bond.

Membrane topology specifies the sidedness of a membrane-associated polypeptide chain: where its N-terminus, C-terminus and intervening protein domains lie relative to the lipid bilayer. Side-specific placement is essential to interpreting a cell-surface receptor.^[ref]

For an original worked example, stipulate a continuous polypeptide chain with its N-terminus outside a biological cell, exactly three complete crossings of the cell membrane, and no additional excursions into the lipid bilayer. Its segments lie, in order, outside, inside, outside, inside. A protein domain between the first and second crossings faces the cytosol; one between the second and third faces the exterior; the C-terminus faces the cytosol. Counting crossings determines these placements without specifying an atomic protein structure.

The proof is a side-switching argument. Assign exterior the sign $+1$ and interior $-1$. Each complete crossing multiplies the sign by $-1$, so after $m$ crossings,An odd number puts the termini on opposite sides, an even number on the same side. This assumes complete crossings of one boundary; a chain that enters and returns to the same side without crossing must not be counted as a complete crossing. Nor does the rule determine which side the N-terminus starts on.

As a constructed accessibility test, put an epitope on the outside segment between crossings two and three, and another on the inside segment between crossings one and two. Stipulate an intact cell membrane that excludes the test antibody and accessible epitopes that bind it. Applying the antibody outside can label only the first epitope. If both become accessible after opening the boundary, the difference tests sidedness under those assumptions. Failure to label an epitope alone is insufficient: it could also be inaccessible because of protein folding or poor antibody affinity. This is a proposed reasoning exercise, separate from the historical mixing experiment below.

The useful product is a correctly identified, active and reproducible protein preparation, not merely a large expression band. I would first examine the coding sequence, protein sequence and available biological information to identify the likely mature chain, protein domains, signal peptides, transmembrane segments, disulfide bonds and required post-translational modifications. A predicted protein structure can guide construct boundaries, but cannot establish that the expressed product will fold or function. A eukaryotic genomic sequence containing introns generally needs replacement by an intron-free Complementary DNA or synthetic coding region for expression in Escherichia coli. I would verify the chosen isoform and full sequence, since a database annotation can be wrong.

The expression host follows from the biochemical requirements. Escherichia coli is inexpensive and convenient for many soluble proteins; yeast, insect or mammalian cells may be preferable for secreted proteins or essential glycosylation. A membrane protein also requires a suitable membrane environment during expression and an appropriate detergent or membrane mimic after extraction. I would preserve biologically necessary domains and modifications. Removing a flexible region to improve yield creates a different construct whose suitability must be justified by the intended analysis.

For a bacterial preparation, I would clone the coding region into an expression vector with a controllable promoter, a suitable ribosome-binding site, a selectable marker and a removable affinity tag. A terminal polyhistidine tag is a practical initial choice, provided the terminus is compatible with activity. Correct reading frame, both junctions and the complete insert must be checked by DNA sequencing. The T7 expression system offers strong inducible expression through a phage RNA polymerase; the original work established selective expression of cloned genes, but strong transcription alone does not guarantee soluble, active product.^[ref]

I would screen small cultures before scale-up, varying induction strength, induction duration and temperature, and comparing total lysate with soluble and insoluble fractions by SDS-PAGE. Empty-vector and uninduced controls identify host bands and background expression; an immunoblot against the tag can help identify the product. Expression at lower temperature or a weaker rate can improve protein folding; persistent insolubility may require changing the construct, host or folding environment. An inclusion body is evidence of abundant insoluble material, not of correctly folded protein. Refolding may be possible, but its yield and recovered activity need independent validation.

Once a small-scale condition produces active soluble material, I would expand the culture or fermentation while monitoring growth and retaining the validated induction conditions. After harvesting, controlled lysis at low temperature, an appropriate buffer solution and protection against proteolysis preserve the product. Centrifugation removes debris; a membrane-associated target instead requires isolation and solubilization of the relevant fraction. I would use immobilized metal affinity chromatography for a polyhistidine-tagged construct, wash away nonspecific binders, and elute under conditions compatible with activity. Tag cleavage, a second affinity step to remove tag and tagged protease, and an orthogonal separation such as ion-exchange chromatography can improve purity. A final size-exclusion chromatography step removes aggregates and separates different assemblies. No single chromatographic peak proves identity or homogeneity.

At each stage I would record protein concentration, total recovered amount and a suitable activity or binding readout, rather than optimizing yield alone. Final checks would include SDS-PAGE, intact or peptide mass spectrometry, a native-size measurement and the expected biological activity. Buffer-only and host-purification controls test whether apparent activity comes from contaminants; comparing tagged and cleaved material tests tag interference. Small frozen aliquots should be used only after checking stability and freeze–thaw effects. Scale-up is justified by recovery of the desired molecular species with retained function, with any differences from the native protein documented.

Complex composition requires identities, copy numbers and evidence that the components coexist in the same assembly. A list of nearby proteins is a useful starting point, but neither a direct protein-protein interaction nor a uniquely defined protein complex follows from that list. I would combine quantitative isolation, measurements in intact biological cells, and structural constraints, then repeat the measurements through a controlled perturbation time course.

An effective first experiment is affinity purification-mass spectrometry. Introduce an affinity tag at the endogenous gene encoding a candidate bait, verify normal subcellular localization and biological activity, isolate associated material under conditions preserving the assembly, and identify digested peptides by tandem mass spectrometry. Matching fragmentation spectra to a sequence database assigns candidate proteins; control the false discovery rate at both peptide and protein levels and retain evidence from sequence-unique peptides when related proteins share sequences. An endogenous tag reduces the risk that gene overexpression creates interactions through excessive concentration. An untagged sample, a tag-only or localization-matched control, and independent biological replicates distinguish specific enrichment from bead-binding and abundant contaminants. Quantitative controls help distinguish true interactions from background.^[ref]

Isolation has selective losses. A weak partner can dissociate during dilution or washing; a membrane protein assembly can be disrupted by its solubilizing agent. Compare extraction conditions, check recovery in the soluble and insoluble fractions, and use reciprocal co-immunoprecipitation from an independent subunit. Treatment with a nuclease tests whether the association depends on DNA or RNA, but removal after extraction can itself destabilize a real nucleic-acid-dependent assembly. Purification from mixed tagged and untagged cell populations, with distinguishable stable isotope labeling, can test whether partners exchange after cell disruption. A reciprocal enrichment supports coassociation; demonstrating a direct contact still requires additional evidence.

For stoichiometry, raw mass spectrometry intensity is insufficient because different peptides have different digestion and ionization efficiencies. Use calibrated peptide standards or carefully normalized quantitative estimates, ideally with several reference subunits. native mass spectrometry measures intact assembly masses and can distinguish candidate subunit counts, while controlled dissociation helps assign subcomplexes. Bound lipids, post-translational modifications, gas-phase losses and heterogeneous occupancy complicate assignment, so check the mass against the summed masses of candidate subunits. Size-exclusion chromatography coupled to multi-angle light scattering independently constrains assembly mass, although an unresolved mixture produces an average and the hydrodynamic size alone is not a molecular mass. Quantitative mass spectrometry of protein complexes can combine interaction strengths, abundance and stoichiometry.^[ref]

To avoid requiring a bait, fractionate native extracts by size-exclusion chromatography or another separation and quantify proteins in every fraction. Correlated elution profiles suggest membership of the same protein complex; comparison across an independent separation helps distinguish coincidence. This co-fractionation mass spectrometry can also reveal shifts from a large assembly into smaller forms after treatment. It may merge different assemblies sharing a subunit, and a failure to coelute does not exclude a transient interaction. chemical cross-linking mass spectrometry adds spatial information: identify pairs of linked residues, translate them into distance restraints appropriate to the reagent and residue accessibility, and ask whether a proposed assembly can satisfy them. A cross-link is a proximity constraint, not automatically a permanent interface; intermolecular assignment is especially difficult for identical subunits.

In living biological cells, proximity labeling captures an interaction neighbourhood before disruptive extraction. A bait fused to TurboID marks nearby proteins with biotin, allowing stringent enrichment and mass spectrometry. The original TurboID work demonstrated useful labeling over roughly ten minutes, which is much faster than older long-labeling implementations.^[ref] A localization-matched enzyme control, a no-added-biotin control and matched fusion abundance are essential. The labeling pulse integrates both spatial proximity and residence time; ten-minute labeling cannot resolve a seconds-long interaction sequence. Changes in ATP, biotin availability, enzyme activity or access to reactive residues can change the labeling signal independently of complex membership. A pulse followed by a chase does not make the covalent label disappear when the partner leaves.

Structural methods distinguish alternative interpretations of these measurements. cryo-electron microscopy can assign ordered subunits, estimate occupancy of resolved features, and separate some compositionally different particle classes. Flexible or small subunits may remain invisible despite being present. X-ray crystallography resolves stable interfaces but selects material that crystallizes. Förster resonance energy transfer between appropriately positioned labels tests nanometre-scale proximity in intact biological cells; single-particle tracking and fluorescence correlation spectroscopy can test comobility and exchange. Label placement, spectral cross-talk and accidental colocalization require controls. None of these techniques by itself reliably inventories every component.

The computational analysis should preserve these distinctions. Construct a protein interaction network with separate edge types for copurification, cross-linking and proximity labeling. Cluster reproducibly supported associations to propose modules, distinguish a stable core from variable accessory components, and integrate localization and measured protein abundance. Models such as AlphaFold 3 can propose interfaces for experimentally supported candidate components, but a confident predicted geometry does not demonstrate that an interaction occurs in the tested condition.^[ref] Test interfaces by site-directed mutagenesis, confirming normal protein folding, expression and localization before interpreting a lost interaction. Evaluate a proposed assembly against independently held-out cross-links or other measurements to reduce circular validation.

For perturbations, use vehicle controls, several doses and early-to-late sampling; randomize preparation and instrument order. Quantify input abundance alongside bait-normalized partner recovery. An illustrative relative recruitment statistic for partner $i$ at time $t$ iswhere $I^{\mathrm{IP}}$ is background-corrected recovered intensity, $b$ is the bait and $A_i$ is input abundance. This is an operational comparison under matched extraction and measurement response, not an absolute occupancy or dissociation constant. A doubled recovered partner signal with doubled input abundance and unchanged bait recovery gives $R_i=1$, illustrating why raw enrichment alone would mislead. Values near the detection limit need uncertainty bounds rather than unstable ratios.

A drug-induced loss of several core components could mean disassembly, degradation, changed localization or poor recovery. Distinguish them with input proteomics, microscopy and native fractionation, then test reversibility after washout and rescue by a drug-resistant target when feasible. For stress, monitor viability and extraction-resistant material; for disease-associated mutations, compare otherwise matched genetic backgrounds and rescue with the normal allele. post-translational modifications may recruit an accessory partner without changing the core. hydrogen-deuterium exchange mass spectrometry can then test interface exposure, but its altered exchange reports accessibility and structural dynamics rather than a new subunit by itself. A convincing remodeling claim is a reproducible change in assembly membership or occupancy, separated from changes in abundance, localization and assay recovery, and connected to a functional consequence.

Dynamic measurements explain which conformations a protein visits, how quickly it exchanges between them, and which transitions control biological activity. A static protein structure identifies possible contacts; protein dynamics can establish whether those contacts form before substrate binding, during enzyme turnover, or when a membrane protein switches between transport states. The useful comparison is therefore among conformational ensembles, transition rates and function under matched conditions.

Consider two interconverting conformations $A$ and $B$. For an ideal two-state system at thermal equilibrium, detailed balance gives $p_A{k}_{AB}=p_B{k}_{BA}$, soHere $G_A,G_B$ are molar Gibbs free energies, $R$ is the molar gas constant, and $T$ is temperature. Measuring only the population ratio cannot identify the exchange timescale: multiplying both rates by the same factor preserves that ratio. Conversely, a measured relaxation rate without populations does not determine the individual forward and reverse rates. Under this model, if $p_B=0.1$ and $k_{\mathrm{ex}}=100{\mathrm{s}}^{-1}$, then $k_{AB}=10{\mathrm{s}}^{-1}$ and $k_{BA}=90{\mathrm{s}}^{-1}$. These illustrative values are a consistency check, not measurements of a particular protein. A driven ATP-consuming cycle need not satisfy detailed balance around the entire cycle.

NMR spectroscopy is particularly powerful for a soluble globular protein. Residue-resolved chemical shifts report local environments; NMR relaxation dispersion measures exchange contributions to line broadening and can detect low-population states exchanging on microsecond-to-millisecond timescales. Different experiments probe faster local fluctuations or slower exchange. Analysis can estimate populations, rates and chemical shift differences, allowing a minor state's environment to be compared with a known ligand-bound state. dihydrofolate reductase provides a concrete example: relaxation-dispersion measurements identified excited conformations resembling states used elsewhere in its catalytic cycle.^[ref] This supports access to functionally relevant conformations before the corresponding chemical step; it does not establish that every detected motion accelerates the bond-making reaction.

This distinction helps test conformational selection against induced fit. If an unbound protein already samples a binding-competent conformation and the ligand stabilizes it, conformational selection contributes. If substantial rearrangement follows initial binding, induced fit contributes. Both can occur in the same mechanism. Measure binding and structural signals over a range of ligand concentrations, include independently measured exchange rates, and fit explicit kinetic models. A matching chemical shift alone does not establish pathway flux, and different models can fit a single relaxation trace. Combining equilibrium populations, rapid-mixing kinetics and site-directed mutagenesis can constrain which route dominates under the tested conditions.

single-molecule Förster resonance energy transfer reveals heterogeneity concealed by ensemble averaging. For a calibrated label pair, the ideal distance dependence iswhere $R_0$ is the Förster distance. Distinct efficiencies and transitions between them can reveal domain closure, opening and dwell times; $r=R_0$ gives $E=1/2$. A distribution of efficiencies is not automatically a distribution of structural states: dye orientation, blinking, label flexibility and photobleaching also contribute. Use donor-only and acceptor-only samples, alternating excitation where appropriate, activity measurements after labeling, and more than one label geometry. For a single memoryless exit with rate $k$, the dwell survival is $e^{-kt}$ and the mean dwell is $1/k$; missed fast events and multiple hidden states violate that simple interpretation.

These measurements connect protein dynamics to allostery. A ligand at one site can change the populations or exchange barriers at a distant functional site, even if the mean protein structure changes little. Measure both sites, compare their thermodynamic coupling and test whether an interface mutation changes coupling while preserving protein folding. hydrogen-deuterium exchange mass spectrometry identifies changes in protection across a protein and is useful for large assemblies. Interpretation needs matched pH and temperature, correction for exchange during analysis, and recognition that protection combines solvent access, hydrogen bonds and structural opening. A protected region can be an interface or a stabilized internal region; it is not direct proof of contact.

For membrane proteins, the environment is part of the experiment. micelles of detergents, lipid bilayer nanodiscs and lipid vesicles can stabilize different conformational ensembles. NMR spectroscopy, electron paramagnetic resonance distance measurements and single-molecule Förster resonance energy transfer can compare cytoplasmic domain movements in these environments. In the beta-2 adrenergic receptor, combined fluorine NMR spectroscopy and double electron-electron resonance showed that agonist occupancy did not fully stabilize one active conformation; interaction with a G protein or a mimetic further favored the active state.^[ref] This explains how ligands with similar binding can differ in signaling efficacy: binding occupancy and population of a productive signaling conformation are distinct quantities.

Ion channels provide an unusually direct connection between molecular switching and function. Patch clamp records individual openings and closures, permitting measurement of conductance, open probability, dwell times and responses to membrane potential or ligand. For $N$ identical independent channels with single-channel current $i$ and open probability $P_o$, the mean current is $Ni{P}_o$. A changed whole-cell current could therefore reflect channel number, conductance or gating; single-channel measurements help separate them. Correlating a conformational probe with electrical activity can assign a structural motion to opening, but a multi-state gating model is usually more realistic than simply equating all structural fluctuations with current-producing transitions. Control membrane integrity, recording bandwidth, label effects and the relevant electrochemical gradient.

For a carrier protein, structural dynamics tests alternating access: the substrate-binding region becomes accessible successively from opposite sides without maintaining an open pore across the lipid bilayer. Measure conformational exchange together with uptake into lipid vesicles, varying substrate, ATP or the driving electrochemical gradient. A conformation trapped by a mutation may be an on-pathway intermediate, an off-pathway dead end or a misfolded state; compare binding, transport and the driving-energy reaction. cryo-electron microscopy classification supplies candidate structural states, but particle-class fractions can be biased by preparation and classification and do not directly provide transition rates. molecular dynamics can suggest connecting routes and transient interactions; predictions must reproduce observables and are limited by sampling and the physical model.

The strongest functional inference comes from perturbing a particular transition and measuring the resulting activity. Preserve abundance, localization, protein folding and binding where possible, then ask whether the measured rate change predicts the functional change. Slow reaction product release may determine enzyme turnover even when chemical conversion is fast; a membrane protein can bind a substrate normally while failing to complete its transport cycle. Biophysical dynamics turns a structural catalogue into a mechanism when state populations, transition rates and activity constrain the same model.

A plausible hypothesis is that broad specificity emerges from a flexible, chemically heterogeneous binding cavity containing overlapping recognition sites, coupled to an energy-driven cycle that exports many different bound molecules. The cavity recognizes combinations of physical properties rather than one unique chemical structure. Different substrates can use different subsets of contacts and different routes through the same multidrug efflux pump. This is a testable mechanism, not a claim that every pump has identical architecture.

The hypothesis has three parts. First, a large cavity contains patches providing hydrophobic contacts, aromatic contacts, hydrogen bonds and electrostatics. A chemically diverse set of substrates may share an aromatic region, a charged group or the ability to partition into the lipid bilayer. Each can make a favorable but different combination of contacts. Internal water can mediate alternative interactions rather than requiring a rigidly preorganized set of donors and acceptors. Second, local side-chain and backbone flexibility allows several cavity shapes. Third, the large-scale transport cycle changes accessibility and affinity so that occupancy of a permissive binding region can be converted into release on the far side.

These ideas have structural precedents. X-ray crystallography of AcrB identified an aromatic, multisite drug-binding region and different conformations in its three subunits, consistent with a functional rotation through binding and export states.^[ref] Further structures distinguished an access pocket and a deeper binding pocket separated by a flexible switch loop.^[ref] The observation supports overlapping recognition and staged movement; the proposed energetic and kinetic roles of each contact still require testing. AcrB is the proton-coupled inner-membrane component of a larger bacterial export assembly, rather than an ATP-powered pump by itself.

A conformational ensemble makes the hypothesis quantitative. Let the unbound pump occupy conformations $j$ with probabilities $p_j$, and let substrate $s$ have an association constant $K_{a,j,s}$ in conformation $j$. If these states equilibrate rapidly before significant transport, a simple equilibrium binding polynomial givesThe expression follows by adding the bound population contributed by each unbound state at low free substrate concentration. Distinct substrates can bind well overall even when their favorable conformations are different. For example, with $p_1=0.9$, $p_2=0.1$, $K_{a,1,s}=10^4{\mathrm{M}}^{-1}$ and $K_{a,2,s}=10^7{\mathrm{M}}^{-1}$, the apparent constant is $1.009\times 10^6{\mathrm{M}}^{-1}$. A minority state dominates the binding contribution. These are illustrative numbers, not measured pump parameters. A working pump is driven and may not equilibrate rapidly, so its transport kinetics cannot in general be reduced to this binding expression.

Permissive recognition is compatible with directional transport only when the cycle is coupled to a driving reaction. For an ATP-binding cassette transporter, ATP binding and ATP hydrolysis couple rearrangement of nucleotide-binding and transmembrane regions. For a proton-driven pump such as AcrB, proton movement down its electrochemical gradient couples to structural changes. Neither substrate affinity alone nor random thermal motion supplies sustained uphill transport. In a tightly coupled model exporting one drug molecule while importing $n$ protons, the molar cycle Gibbs free energy iswhereHere $a$ denotes dimensionless thermodynamic activity, $F$ the Faraday constant, $\psi$ electric potential, and $z_D$ the charge of the transported drug species. Forward operation requires $\Delta G_{\mathrm{cycle}}<0$; equilibrium stall has equality. This states an energetic bound under the stated coupling assumption, not a measured proton-to-drug ratio for AcrB. Mixed protonation states, coupling slippage and alternative pathways require a more detailed model.

Several predictions distinguish flexible multisite recognition from an indiscriminately sticky cavity. A mutation removing one aromatic contact should disproportionately affect a subset of substrates that use that region, while leaving others relatively intact. Altering a common gating element may impair many substrates despite preserving some equilibrium binding. Rigidifying a flexible recognition loop could narrow the range even when transport of a favored substrate survives. Different drugs may compete strongly, weakly or asymmetrically depending on overlap and pathway occupancy; failure of simple competitive kinetics would not alone prove distinct sites in a driven, multi-state system.

Test these predictions with a chemically varied panel, including transported compounds and matched nontransported controls. Measure direct transport in lipid vesicles or another defined system while controlling orientation, pump amount, membrane leak and the driving gradient. For a proton-coupled pump, vary pH and membrane potential separately where possible and include an energy-collapse control; establish that the collapse does not merely destroy membrane integrity. For an ATP-driven pump include no-ATP and hydrolysis-defective controls. Measure binding and driving-energy consumption independently, because drug-stimulated ATP hydrolysis or proton flow can be uncoupled from productive export. Growth-based resistance alone is insufficient: altered drug uptake, metabolism and expression also change survival.

Use cryo-electron microscopy or X-ray crystallography with several chemically different drugs to test different contact maps and cavity shapes, then validate those differences by targeted mutations. Confirm expression, assembly, membrane localization and protein folding for every altered pump. molecular dynamics can predict alternative entry routes and local reorganization, but force-field choices, drug protonation and limited sampling must be varied or checked; a docking score alone is not evidence of transport. single-molecule Förster resonance energy transfer or electron paramagnetic resonance can test whether different drugs stabilize different dynamic states and whether the driving reaction changes state occupancy.

Finally, membrane partitioning may explain part of the apparent range: a pump can collect chemically varied compounds that share access to the same membrane-facing route. Measure drug partitioning and free aqueous concentration, since equal added concentrations need not give equal local exposure at the pump. The strongest support would be substrate-specific contact and dynamics changes, preserved transport energetics, and direct export measurements showing that one adaptable recognition apparatus feeds a shared directional cycle.

phosphoinositides provide changing membrane identities that recruit, activate and release the endocytic machinery. The strongest evidence combines specific lipid-binding measurements, acute lipid manipulation, genetic rescue and time-resolved imaging. An altered uptake endpoint alone cannot identify whether the defect is pit initiation, membrane deformation, membrane fission, uncoating or later endosome traffic.

phosphoinositides are phosphorylated derivatives of phosphatidylinositol. Their headgroups differ in phosphate position, so chemically similar membrane anchors carry distinct recognition signals. At the plasma membrane, phosphatidylinositol 4,5-bisphosphate supports recruitment and activation of multiple components of clathrin-mediated endocytosis, including the AP-2 complex, epsin and dynamin. Binding can involve both electrostatic attraction and stereospecific recognition; showing binding to a highly charged artificial surface does not establish physiological selectivity. Compare equal-charge membranes with different headgroups, vary the target lipid at constant total charge, and verify that a binding-site mutation preserves protein folding.

A decisive experiment is to remove phosphatidylinositol 4,5-bisphosphate rapidly after the biological cell has developed normally. Chemically induced recruitment of a lipid phosphatase to the plasma membrane caused loss of endocytic coats and impaired uptake, giving a causal link on a timescale much shorter than a constitutive knockout.^[ref] A catalytically inactive phosphatase, recruitment without the active enzyme and monitoring of lipid depletion separate enzyme action from recruitment artifacts. Because the phosphatase converts one phosphoinositide into another, the perturbation changes both substrate and product; it is not equivalent to selectively deleting one molecular interaction. Recovery of lipid and coat assembly, or an independent depletion method, strengthens specificity.

That experiment supports a requirement for phosphatidylinositol 4,5-bisphosphate, but does not by itself assign its action to one protein. Multiple coat and actin regulators bind the same lipid. To isolate a particular recruitment step, compare normal and lipid-binding-defective AP-2 complexes at matched abundance, test cargo binding independently, and assay membrane association and internalization separately. In a reconstitution, purified adaptors, clathrin, defined lipid vesicles and a cargo-bearing membrane can distinguish direct lipid-dependent assembly from secondary changes in cell physiology. The interpretation must also account for membrane tension, which can change the requirement for actin-generated force.

Removal of the same lipid is needed later in the pathway. synaptojanin is a phosphoinositide phosphatase whose loss in mouse neurons caused abnormal phosphoinositide metabolism, accumulation of coated intermediates and defects in synaptic vesicle recycling.^[ref] This establishes that productive traffic requires turnover as well as production of the lipid. A reasonable mechanism is that dephosphorylation weakens membrane binding of adaptors after budding, permitting coat release and component reuse. Constitutive loss can also affect development and several trafficking steps, so the morphological phenotype should be combined with acute interventions and rescue by normal versus catalytically defective synaptojanin. Neither an increased number of coated profiles nor reduced synaptic transmission alone uniquely identifies defective uncoating.

Different phosphoinositides can act sequentially. Experiments implicating phosphatidylinositol 3,4-bisphosphate and PI3K-C2α in late coated-pit maturation linked local lipid production to recruitment of SNX9, a membrane-remodeling factor.^[ref] The mechanistic point is a timed recruitment signal, rather than a permanently uniform membrane composition. Compare kinase depletion with rescue by a normal or catalytic mutant, measure pit lifetimes and morphology, and verify that cargo remains available at the surface. A fluorescent clathrin punctum can disappear by internalization, disassembly or movement out of the observation plane; an independent scission or uptake assay is necessary.

Live imaging provides temporal information that bulk lipid extraction lacks. Coincidence-detecting sensors were developed to report phosphoinositides specifically at clathrin-associated structures and follow their conversion during traffic.^[ref] A probe's fluorescence reports its binding equilibrium, geometry and accessibility, rather than an absolute local lipid count. Overexpressed probes can buffer the lipid being measured; some domains bind soluble headgroups as well. Use low expression, lipid-binding-defective probes, known enzymatic perturbations and an independent reporter. Sensor arrival after a coat marker is evidence about accessible lipid at that time, not necessarily the instant of synthesis.

Downstream, phosphatidylinositol 3-phosphate helps recruit effectors to early endosomes, while phosphatidylinositol 3,5-bisphosphate is associated with later endolysosomal function. These roles should be separated experimentally from initial uptake. Pulse-label a surface cargo, remove extracellular label, and follow its delivery, recycling and degradation. If uptake is normal but degradation fails, the result supports a sorting or maturation defect rather than failed entry. General inhibition of all phosphoinositide kinases is especially difficult to interpret because it perturbs several compartments simultaneously.

A useful synthesis is a regulated cycle: local lipid synthesis makes an assembly site competent; coat and curvature factors recognize that site; membrane deformation and scission proceed; lipid conversion changes the set of favored partners; uncoating and endosomal sorting follow. This is a model assembled from distinct experiments, not proof that every endocytic event follows one rigid lipid sequence. The evidence supports both spatial identity and temporal switching: a lipid can be required for assembling an endocytic structure, while its subsequent removal is required for that structure to complete its task.

In single-molecule force spectroscopy of titin, one end of the protein is attached to a surface and the other to an atomic force microscope cantilever. Moving the support stretches the molecule; a calibrated cantilever deflection measures the force through $f=k_c\delta$. The molecular extension is the imposed separation minus cantilever deflection and other instrumental offsets, rather than the uncorrected support displacement.

At first, increasing extension removes conformational slack from unstructured segments. Their conformational entropy decreases and the resisting force rises. A folded protein domain then unfolds when a thermally activated transition becomes likely under load. Its residues join the stretched chain, increasing the available polymer contour length. At almost the same imposed separation, the newly released segment has slack: the force drops. Further pulling straightens this longer chain until another domain unfolds. Repetition produces a sawtooth sequence; each rising branch mainly measures stretching between unfolding events, and a peak marks the end of such a branch.

The peak height measures the resistance to unfolding under the particular loading history, not a direct equilibrium free energy or an invariant breaking force. Random unfolding times, loading rate, domain identity, attachments, and cantilever compliance affect the record. Releasing tension can allow protein folding, but refolding has its own kinetics and need not retrace the loading curve. Distinct unfolding events explain how a long protein can absorb extension in steps rather than failing at a single threshold.

Source illustration TODO: Figures A and B are absent in the held source and archive parent. This explanation uses the surviving sawtooth description; it supplies no recovered peak heights, spacings, or domain counts.

A protein is synthesized as a polypeptide whose sequence constrains its possible interactions. Protein folding is the acquisition of a functional three-dimensional structure: local hydrogen bonds organize secondary structure, while packing, electrostatic interactions and burial of nonpolar groups through the hydrophobic effect stabilize the overall fold. Some proteins also form protein disulfide bonds. Folding reduces the chain's conformational entropy, but the relevant balance includes the entropy of the surrounding water; it is the total Gibbs free energy that is minimized at fixed pressure and temperature.

A folding funnel describes a biased but rugged energy landscape: increasingly native-like conformations become favorable, while barriers can trap intermediates. The chain therefore does not have to test every possible conformation in a uniform random search. Molecular chaperones can prevent protein aggregation and help escape kinetic traps; some proteins remain disordered or require partners, so a unique isolated compact fold is not universal.

The ribonuclease A refolding experiment connects this thermodynamic account to a measurement. Unfolding the enzyme with urea while reducing its disulfide bonds removes activity; suitable removal of the denaturant and restoration of disulfide bonds recover activity. Oxidizing while the chain remains unfolded instead produces incorrectly paired disulfides and little activity. Thus sequence, solvent conditions and the route past kinetic traps all matter; restoration of enzyme activity provides a functional test of folding.

The central dogma of molecular biology concerns sequence information: DNA can be copied by DNA replication; transcription makes RNA from DNA; and translation makes a protein from messenger RNA. The familiar $\mathrm{DNA}\to \mathrm{RNA}\to \mathrm{protein}$ diagram is not an assertion that all information transfer is one-way: reverse transcription and RNA replication are compatible with the dogma. Its key exclusion is transfer of a protein's amino-acid sequence back into nucleic-acid sequence by a general templating mechanism.

DNA is a polymer of deoxyribonucleotides with a sugar–phosphate backbone joined by phosphodiester bonds. Its usual DNA double helix contains antiparallel strands with complementary bases, adenine paired with thymine and guanine with cytosine. The base sequence stores inherited information; complementary pairing supports accurate copying and repair. A strand has distinct $5^{\prime }$ and $3^{\prime }$ ends, and ordinary chain synthesis extends the $3^{\prime }$ end. Packaging into chromosomes compacts and regulates access to the genetic material.

RNA uses ribose, with a $2^{\prime }$ hydroxyl group, and uracil in place of thymine. It is usually single-stranded but forms extensive paired secondary and tertiary structures. Messenger RNA conveys coding information, transfer RNA couples codons to amino acids, and ribosomal RNA provides both structural organization and catalysis within the ribosome. Other RNA molecules regulate expression or catalyse reactions. Thus RNA is not merely a passive intermediate.

Proteins are polypeptides of amino acids linked by peptide bonds, read from an amino terminus to a carboxyl terminus. Their primary sequence guides protein folding; backbone hydrogen bonds organize helices and sheets, while hydrophobic, electrostatic and other interactions produce tertiary and sometimes quaternary protein structure. Their functions include catalysis, transport, signalling, mechanical support and molecular movement. Sequence alone does not guarantee function: folding, modifications, partners and cellular conditions matter. During translation, a ribosome reads successive triplet codons in messenger RNA, with charged transfer RNA molecules supplying the corresponding amino acids; initiation and termination define the reading frame.

Protein primary structure is the ordered amino acid sequence of a polypeptide, linked by covalent peptide bonds. The approximately planar peptide bond restricts local geometry, while backbone torsion angles give conformational freedom subject to steric exclusion. Protein secondary structure comprises local backbone arrangements, especially the alpha helix, with backbone hydrogen bonds between residues $i$ and $i+4$, and the beta sheet, whose strands are joined by backbone hydrogen bonds. Turns and loops connect these elements. Protein tertiary structure is the full three-dimensional organization of a single chain, often including several protein domains. Protein quaternary structure is the arrangement of multiple chains in a protein complex.

Protein folding is governed by the Gibbs free energy of the chain together with its solvent, not by the chain's energy alone. Folding reduces the chain's conformational entropy, but can gain solvent entropy through the hydrophobic effect, burying nonpolar side chains away from water. Favorable hydrogen bonds, Van der Waals forces, electrostatic interactions and sometimes covalent disulfide bonds stabilize particular structures. Steric repulsion prevents atomic overlap. At fixed temperature and pressure, the native ensemble is favored when its total $\Delta G=\Delta H-T\Delta S$ is lower than competing ensembles. The balance depends on the solvent, pH, salt and ligands. Molecular chaperones help avoid aggregation or kinetic traps; a stable fold is not a perfectly rigid conformation, and some proteins have disordered regions.

For a soluble globular protein, a typical pattern is a nonpolar core and a polar, hydrated surface. A transmembrane protein instead presents nonpolar side chains to the hydrocarbon interior of the lipid bilayer. Membrane-spanning alpha helices satisfy their polar backbone groups through internal hydrogen bonds; a roughly membrane-thickness helix commonly contains about twenty residues, depending on tilt and bilayer thickness. Multiple helices can enclose polar channels or binding sites. Membrane-spanning beta barrels likewise expose mainly nonpolar groups outward towards lipid while arranging backbone hydrogen bonds between strands and often lining an aqueous pore with polar groups. Exposed loops and domains contacting water can resemble soluble proteins. Not every membrane-associated protein spans the membrane: peripheral attachment and lipid anchoring are distinct possibilities.

The organizing distinction is the environment of each surface: water favors accessible polar groups, while the membrane core favors outward-facing nonpolar groups. Buried polar groups can still be essential to a transport pathway or catalytic site.

A protein is a biological molecule made of one or more polypeptide chains: ordered amino acid residues joined by peptide bonds. Biological translation assembles a chain in the order specified by messenger RNA codons. Protein folding then brings parts of that chain into spatial relationships that support its function. See Cooper, The Cell: protein composition and structure. These processes can overlap in a biological cell; the sequence-to-shape explanation does not require waiting until biological translation finishes before any folding begins. See Cooper, The Cell: protein folding and processing.

The useful connection is from information to physical work. A protein's protein primary structure records an order; its protein tertiary structure can bring distant amino acid residues together at an active site. An enzyme uses such an arrangement to recognize a substrate and accelerate a chemical reaction. Other proteins serve as receptors, membrane transport proteins or structural material. For example, actin assembles into filaments whose mechanical properties can be described by biopolymer mechanics. See Alberts et al., Molecular Biology of the Cell: protein function and binding.

Order matters beyond composition. Let A stand for alanine and M for methionine, and read from the N-terminus to the C-terminus. The illustrative strings AMAMAMAMAMAM and AAAAAAMMMMMM each contain exactly six A and six M amino acid residues. Each has $12-1=11$ peptide bonds when made into one unbranched polypeptide chain. In the first string all eleven neighboring pairs have different letters; in the second only the pair at positions 6 and 7 does. A composition histogram therefore loses information about which amino acid residues are neighbors. Their arrangements can affect protein folding and function; these short invented strings neither specify a known functional protein nor establish what shape either would adopt.

Protein structure is a moving arrangement, not a permanently rigid outline. Substrate binding can change an enzyme's shape through induced fit, and a functional protein can include flexible regions. Sequence, surroundings and interacting molecules must therefore be considered together. See Alberts et al.: binding, conformational changes and protein function.

The protein backbone is the repeating chain of chemical atoms that connects successive amino acid residues, including their peptide bonds. The attached groups that distinguish amino acids project from this shared framework. Protein folding changes the framework's spatial arrangement while ordinarily preserving its sequence connectivity. See Cooper: polypeptide backbone and attached groups.

Protein folding is the process by which a polypeptide chain acquires an organized spatial arrangement. The interactions of its amino acid residues with one another and the surroundings favor some arrangements over others. Protein folding can bring chemically useful groups together at an active site without changing their order along the protein backbone. Its importance is practical: knowing a sequence alone does not tell us whether a sample has the structure needed for function. See Cooper: acquiring functional protein structure.

The ribonuclease A refolding experiment showed that an isolated protein could recover its native properties without a pre-existing folded template under suitable laboratory conditions. Anfinsen interpreted this through a thermodynamic hypothesis: the native arrangement minimizes the whole system's Gibbs free energy in the appropriate environment. His Nobel lecture was delivered on 11 December 1972 and published in Science in 1973. The specified environment is part of the claim, not a disposable qualification. See Anfinsen, Principles that Govern the Folding of Protein Chains, Science 181, 223–230 (1973): Nobel lecture, especially p. 223.

This does not imply that every protein rapidly folds unaided. Molecular chaperones can assist protein folding and reduce protein aggregation; required partners, surroundings and time still matter. Goloubinoff and colleagues' 1989 reconstitution experiments demonstrated assistance from two molecular chaperones and ATP in recovering an active enzyme from unfolded chains. This is experimental evidence that assistance can matter even when the chains already have their specified sequences. See Goloubinoff, Christeller, Gatenby and Lorimer, 1989: chaperone-assisted reconstitution of an active enzyme.